Bionano Genomics (BNGO) Retained Earnings (2017 - 2026)

Bionano Genomics has disclosed Retained Earnings across 10 years of filings, most recently posting $12000.0 for Q1 2026.

• Retained Earnings for Q1 2026 came in at $12000.0, down 14.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $12000.0 (down 14.29% YoY), and the FY2025 annual result was $17000.0, up 100.0% from the prior year.
• Retained Earnings came in at $12000.0 for Q1 2026 at Bionano Genomics, down from $17000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $23000.0 in Q4 2023 to a low of -$711.7 million in Q3 2025.
• The 5-year median for Retained Earnings is -$278.2 million (2022), against an average of -$289.8 million.
• Peak annual rise in Retained Earnings reached 187.5% in 2025, while the deepest fall reached 23439366.67% in 2025.
• Bionano Genomics' Retained Earnings stood at -$348.7 million in 2022, then surged by 100.01% to $23000.0 in 2023, then sank by 3014121.74% to -$693.2 million in 2024, then jumped by 100.0% to $17000.0 in 2025, then decreased by 29.41% to $12000.0 in 2026.
• The last three Retained Earnings figures came in at $12000.0 (Q1 2026), $17000.0 (Q4 2025), and -$711.7 million (Q3 2025), per Business Quant data.